Bellus Health shareholders say yes to US$2B GSK takeover
BELLUS Health Inc. Announces Voting Results from Special Meeting of Shareholders
Alliance Entertainment Reports Third Quarter and Nine Month Fiscal 2023 Financial Results
BELLUS Santé inc. convoque une assemblée extraordinaire des actionnaires concernant l’acquisition de la société par GSK
BELLUS Health Inc. Calls Special Shareholders' Meeting in Connection with GSK Acquisition
BELLUS Health Reports First Quarter 2023 Financial Results and Business Highlights
BELLUS Santé annonce ses résultats financiers et faits saillants pour le premier trimestre de 2023
BELLUS Health Reports First Quarter 2023 Financial Results and Business Highlights
Tommy Hilfiger, Mercedes-AMG PETRONAS Formula One Team e Awake NY lanciano una collaborazione al Grand Prix di Miami
Crackle Connex Showcases Its Unique Advertising and Media Offering at IAB Newfronts
The St. Joe Company Announces the Opening of the 255-suite Embassy Suites by Hilton Panama City Beach Resort
BELLUS Health Announces Meeting Updates
BELLUS Santé annonce de l’information récente au sujet de l’assemblée
BELLUS Health Announces Meeting Updates
Was This Acquisition a Savvy Play by This Big Pharma Stock?
Why Shares of Bellus Health Skyrocketed This Week
Bellus Health (BLU) Stock Up 99% on $2B Buyout Offer From GSK
Biopharma stock soars on takeover deal plus more daily small cap and micro cap movers
GSK reaches agreement to acquire late-stage biopharmaceutical company BELLUS Health
Why BELLUS Health Stock Is Rocketing Higher Today
Bellus Health Soars 98% As GSK Joins Buyout Bonanza With $2 Billion Deal
Bellus Health's stock climbs on GSK deal, while Goldman Sachs is hurt by a revenue miss
GSK pays £1.6bn for Canada's Bellus Health
GSK to acquire U.S.-based BELLUS Health for $14.75 per share
BELLUS Health Announces Positive Results from its Phase 1 Bioavailability Equivalence Study Evaluating Once-Daily Extended-Release Formulation of Camlipixant in Comparison to Twice-Daily Immediate Release Formulation
Wall Street Analysts Think Bellus (BLU) Could Surge 156.01%: Read This Before Placing a Bet
BELLUS Health Reports Year 2022 Financial Results and Business Highlights
BELLUS Health to Participate in the Cowen 43rd Annual Health Care Conference
Bellus Health: Building Momentum Around CALM, SOOTHE Studies
Bellus Health (BLU) Reports Q3 Loss, Misses Revenue Estimates
BELLUS Health Reports Third Quarter 2022 Financial Results and Business Highlights
Is Bellus Health (BLU) Outperforming Other Medical Stocks This Year?
BELLUS Health to Present Clinical Data from Phase 2b SOOTHE Trial of BLU-5937 at the CHEST Annual Meeting
Bellus: Expected Phase 3 Start Makes This A Long-Term Play
BELLUS Health to Present Clinical Data from Phase 2b SOOTHE Trial of BLU-5937 at the European Respiratory Society International Congress 2022
BELLUS Health Reports Second Quarter 2022 Financial Results and Business Highlights
BELLUS Health Closes US$153 Million Public Offering of Common Shares in Canada and the United States
Why BELLUS Health Stock Fell Today
BELLUS Health Announces Pricing of US$153 Million Public Offering in Canada and the United States
BELLUS Health Shares Slide On Public Offering Of Shares In Canada And US
BELLUS Health Announces the Launch of a Public Offering of Common Shares in Canada and the United States
Bellus Health Announces Positive End-of-Phase 2 Meeting with the FDA and its CALM Phase 3 Program for BLU-5937 in Refractory Chronic Cough
Has Bellus Health (BLU) Outpaced Other Medical Stocks This Year?
BELLUS Health to Participate in the William Blair Biotech Focus Conference
This Small-Cap Innovator is Flying High
Here's Why Bellus Health (BLU) is a Great Momentum Stock to Buy
4 Biotech Stocks With Bright Prospects to Buy Amid Recovery
Are Medical Stocks Lagging Bellus Health (BLU) This Year?
BELLUS Health to Participate in the Jefferies Healthcare Conference
Is Bellus Health (BLU) Stock Outpacing Its Medical Peers This Year?